Randomized phase III trial on niraparib - TSR-042 (dostarlimab) vs physician's choice CHEmotherapy in recurrent ovarian, fallopian tube or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33)

被引：0

作者：

Lorusso, D. ^{[1
,2
]}

Musacchio, L. ^{[1
]}

Pignata, S. ^{[3
]}

Braicu, E. I. ^{[4
]}

Cibula, D. ^{[5
]}

Colombo, N. ^{[6
]}

Frenel, J-S. ^{[7
]}

Zagouri, F. ^{[8
]}

Carbone, V. ^{[1
]}

Ghizzoni, V. ^{[1
]}

Giolitto, S. ^{[1
]}

Giudice, E. ^{[1
]}

Landolfo, C. ^{[1
]}

Perri, M. T. ^{[1
]}

Ricci, C. ^{[1
]}

Salutari, V. ^{[1
]}

Scambia, G. ^{[9
]}

机构：

[1] Fdn Policlin Univ Agostino Gemelli IRCCS, Dept Women & Child Hlth, Div Gynecol Oncol, Rome, Italy

[2] Fdn Policlin Univ Agostino Gemelli IRCCS, Catholic Univ Sacred Heart, Dept Life Sci & Publ Hlth, Rome, Italy

[3] IRCCS Fdn Pascale, Ist Nazl Tumori, Urol & Gynecol Dept, Naples, Italy

[4] Tumor Bank Ovarian Canc Network TOC & Biostat, Charite Berlin, Berlin, Germany

[5] Charles Univ Prague, Gen Fac Hosp Prague, Fac Med 1, Dept Obstet & Gynecol, Prague, Czech Republic

[6] IEO Ist Europeo Oncol, Dept Gynecol Oncol, Milan, Italy

[7] ICO Inst Cancerol Ouest Rene Gauducheau, Dept Med Oncol, St Herblain, France

[8] Alexandra Hosp, Sch Med, Dept Clin Therapeut, Athens, Greece

[9] Fdn Policlin Univ A Gemelli, IRCCS, UOC Ginecol Oncol & MITO, Dipartimento Salute Donna & Bambino & Salute Pubb, Rome, Italy

来源：

关键词：

D O I：

10.1016/j.annonc.2021.08.1258

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

816TiP

引用

页码：S768 / S769

页数：2